Celltrion | 068270 - 流动负债

金融业

KRW

KRW 759.44B

现金及等价物

KRW 49.87B

KRW 107.42B

KRW 470.6B

KRW 283.62B

KRW 161.31B

股息收益率

0.41

KRW 12.08B

KRW 17.79B

1.07K

EPS每股收益

KRW 1.58K

股本和储备

KRW 435.96B

KRW 46.98B

债务利息支出

KRW 19B

KRW 621.35M

KRW 412.27B

KRW 42776.62B

KRW 8.88B

KRW 140.68B

KRW 13.72B

普通股股本

KRW 218.61M

67.83

KRW 10.5B

KRW 1150B

销售和管理费用

KRW 12.71B

KRW 122.94B

贸易债权人

KRW 78.68B

应收帐款人

KRW 2049.53B

	流动负债	更改		日
Akebia Therapeutics	USD 173.88M		10.95M	2026-03
Alaunos Therapeutics	USD 595K		218K	2026-03
Avita Medical	AUD 62.68M		77K	2025-12
Celltrion	KRW 283.62B		3.72T	2025-12
Dianthus Therapeutics	USD 38.28M		7.55M	2026-03
Ionis Pharmaceuticals	USD 717M		66M	2026-03
IQVIA Holdings	USD 8.33B		9M	2026-03
Moderna	USD 2.4B		408M	2026-03
Organon & Co	USD 2.5B		110M	2026-03
Revvity	USD 1.24B		92.6M	2026-03
Tectonic Therapeutic	USD 12.96M		3.29M	2026-03
Viatris	USD 6.81B		284M	2026-03
Xeris Pharmaceuticals	USD 118.59M		9.02M	2026-03